MRC Clinical Trials Unit at UCL

The Medical Research Council Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases, cancer and neurodegenerative diseases, and delivering swifter and more effective translation of scientific research into patient benefits. We do this by designing and conducting innovative clinical trials, and developing methodological advances in study design, conduct and analysis. We also carry out observational studies to evaluate the impact of new interventions in routine care. Our research helps to improve healthcare in the UK and around the world. Smarter studies. Global impact. Better health

Clinical trials,clinical trials methodology,statistics,medical statistics,clinical research,cancer,infectious diseases,neurodegenerative diseases,medical research,phase iii clinical trials,multi-arm multi-stage trials,patient and public involvement (ppi),postgraduate study,and capacity building

Mrc clinical trials unit at ucl operates in the Higher education industry.

Mrc clinical trials unit at ucl's revenue is 11m - 100m

Mrc clinical trials unit at ucl has 51 - 200 employees.